
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Feb. 8, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Feb. 8, 2024
Language: Английский
Sensors and Actuators B Chemical, Journal Year: 2024, Volume and Issue: 417, P. 136132 - 136132
Published: June 11, 2024
Language: Английский
Citations
5Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 67(11), P. 9104 - 9123
Published: June 3, 2024
Amyloid-β oligomers (AβOs), crucial toxic proteins in early Alzheimer's disease (AD), precede the formation of Aβ plaques and cognitive impairment. In this context, we present our iterative process for developing novel near-infrared fluorescent (NIRF) probes specifically targeting AβOs, aimed at AD diagnosis. An initial screening identified compound
Language: Английский
Citations
4Dyes and Pigments, Journal Year: 2025, Volume and Issue: unknown, P. 112680 - 112680
Published: Jan. 1, 2025
Citations
0Coordination Chemistry Reviews, Journal Year: 2025, Volume and Issue: 535, P. 216625 - 216625
Published: March 19, 2025
Language: Английский
Citations
0bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 2, 2024
Aggregation of microtubule-associated protein tau (MAPT/tau) into conformationally distinct fibrils underpins neurodegenerative tauopathies. Fluorescent probes (fluoroprobes), such as thioflavin T (ThT), have been essential tools for studying aggregation; however, most them do not discriminate between amyloid fibril conformations (polymorphs). This gap is due, in part, to a lack high-throughput methods screening large, diverse chemical collections. Here, we leverage advances adaptive differential scanning fluorimetry (paDSF) screen the Aurora collection 300+ fluorescent dyes against multiple synthetic polymorphs. screen, coupled with orthogonal secondary assays, revealed pan-fibril binding chemotypes, well fluoroprobes selective subsets fibrils. One fluoroprobe recognized pathology
Language: Английский
Citations
3Dyes and Pigments, Journal Year: 2024, Volume and Issue: 224, P. 111993 - 111993
Published: Jan. 28, 2024
As one of the expensive and heavy illnesses, Alzheimer's disease (AD) has plagued mankind for a long time. The deposition amyloid-β (Aβ) plaques in brain is AD's main early pathological characteristic, also growing body evidence shows Aβ good diagnostic AD. In recent years, near-infrared fluorescence (NIRF) imaging emerged with real-time, safe, low-cost technology as promising tool diagnosis. process development AD, gone through monomer, oligomer to insoluble fiber process. Therefore, it useful necessary develop NIRF probes that can specifically detect at various stages. this review, we summarized recognize different We focused on design strategies, optical properties, dynamics characteristics, discussed structural characteristics types these probes. believe review will provide some ideas
Language: Английский
Citations
2ACS Omega, Journal Year: 2024, Volume and Issue: 9(8), P. 8615 - 8631
Published: Feb. 15, 2024
Pollution is ubiquitous, and much of it anthropogenic in nature, which a severe risk factor not only for respiratory infections or asthma sufferers but also Alzheimer's disease, has received lot attention recently. This Review aims to investigate the primary environmental factors their profound impact on disease. It underscores pivotal role multidimensional imaging early disease identification prevention. Conducting comprehensive review, we delved into plethora literature sources available through esteemed databases, including Science Direct, Google Scholar, Scopus, Cochrane, PubMed. Our search strategy incorporated keywords such as "Alzheimer Disease", "Alzheimer's", "Dementia", "Oxidative Stress", "Phytotherapy" conjunction with "Criteria Pollutants", "Imaging", "Pathology", "Particulate Matter". result complex biological exacerbated by infiltration airborne particles gases that surreptitiously breach nasal defenses traverse brain, akin Trojan horse. Various modalities noninvasive techniques have been harnessed identify progression its incipient stages. However, each approach possesses inherent limitations, prompting exploration unified technique under single umbrella. Multidimensional stands linchpin detecting forestalling relentless march Given intricate etiology condition, identifying prospective candidate may take decades, rendering development multimodal an imperative. research pressing need recognize chronic ramifications invisible particulate matter advance our understanding insidious contribute
Language: Английский
Citations
2Journal of Colloid and Interface Science, Journal Year: 2024, Volume and Issue: 670, P. 576 - 584
Published: May 18, 2024
Language: Английский
Citations
2Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)
Published: May 21, 2024
Tauopathies, including Alzheimer's disease and Frontotemporal Dementia, are debilitating neurodegenerative disorders marked by cognitive decline. Despite extensive research, achieving effective treatments significant symptom management remains challenging. Accurate diagnosis is crucial for developing therapeutic strategies, with hyperphosphorylated protein units tau oligomers serving as reliable biomarkers these conditions. This study introduces a novel approach using nanotechnology to enhance the diagnostic process tauopathies. We developed humanized ferritin nanocages, nanoscale delivery system, designed encapsulate transport tau-specific fluorophore, BT1, into human retinal cells detecting neurofibrillary tangles in tissue, key marker of The BT1 living was successfully achieved through demonstrating efficient encapsulation derived from induced pluripotent stem cells. Our experiments confirmed colocalization pathological forms cells, highlighting method's potential identifying Using nanocages represents contribution nanobiotechnology, particularly diagnostics. method offers promising tool early detection implications improving exemplifies integration biomedical science, expanding frontiers nanomedicine techniques.
Language: Английский
Citations
2Talanta, Journal Year: 2024, Volume and Issue: 277, P. 126362 - 126362
Published: June 5, 2024
Language: Английский
Citations
2